The European Medicines Agency has opened a public consultation on the sixth revision of its guideline on the acceptability of names for human medicines.
The current update of this guideline provides further recommendations on the requirements for acceptability and submission of proposed (invented) names.
It also clarifies:
- Specific aspects of the criteria applied to address safety and public-health concerns
- International-non-proprietary-name issues
- Product-specific concerns
- The procedure for submission of proposed (invented) name requests.
The updated guideline is open for comments until 30 August 2013.